EUVIMEDEUVIMED entdecken
Crossref

A dendritic cell autophagy–neutrophil axis limits intratumoral STING immunotherapy

Adriana Loverre iD, Bakhos Jneid iD, Fabien Delisle, Magali Genest iD, Chantal Alkhoury iD, Konstantina Antoniadou iD, Nicolas Manel iD

Science Immunology · 14.08.2026 · 11 (122)

DOI: 10.1126/sciimmunol.adw6399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Immunology, erschienen am 14.08.2026. Verfasst von Adriana Loverre und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institut Curie, PSL Research University, INSERM U932, Paris, France. Hauptthemen laut MEDLINE: Autophagy, Dendritic Cells, Immunotherapy, Neutrophils. Die Arbeit nennt 46 Literaturangaben. Gefördert von: H2020 European Research Council, Agence Nationale de la Recherche, Fondation pour la Recherche Médicale.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cyclic GMP-AMP synthase (cGAS)–stimulator of interferon genes (STING) pathway promotes tumor immunogenicity, but intratumoral STING agonists, despite strong preclinical efficacy, have shown limited clinical efficacy. The mechanisms restricting therapeutic STING activation remain unclear. In mice, intratumoral delivery of the endogenous STING ligand cyclic guanosine monophosphate–adenosine monophosphate (GMP-AMP) (cGAMP) using viruslike particles (VLPs) preferentially activates STING in dendritic cells and primes circulating tumor-specific T cells. Using this system, we investigated mechanisms limiting effective STING-based immunotherapy. STING-induced type I interferon signaling was dispensable for cGAMP-VLP–mediated tumor control. In contrast, dendritic cell autophagy was required for generating circulating antitumor CD8 T cells and for regulating baseline neutrophil levels in lymph nodes. cGAMP-VLP overrode this regulation, inducing neutrophil accumulation in tumors and draining lymph nodes that limited efficacy. Neutrophil depletion enhanced tumor control through mechanisms involving neutrophil elastase and programmed cell death 1 ligand 1. These findings reveal that defective dendritic cell autophagy and neutrophil-mediated immunosuppression, rather than insufficient interferon signaling, hinder the effectiveness of intratumoral STING immunotherapy in preclinical mouse models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyDendritic CellsImmunotherapyNeutrophilsMembrane ProteinsAnimalsMiceSTING ProteincGAS-STING Signaling PathwayNucleotides, CyclicMice, Inbred C57BLFemale

Substanzen

Membrane ProteinsSTING ProteinSting1 protein, mousecyclic guanosine monophosphate-adenosine monophosphateNucleotides, Cyclic

Autor:innen und Institutionen

  • Institut Curie, PSL Research University, INSERM U932, Paris, France.
  • Stimunity, Paris, France.

ORCID-Profile: Adriana Loverre, Bakhos Jneid, Magali Genest, Chantal Alkhoury, Konstantina Antoniadou, Nicolas Manel

Förderung

  • H2020 European Research Council
  • Agence Nationale de la Recherche
  • Fondation pour la Recherche Médicale
  • Fondation ARC pour la Recherche sur le Cancer
  • Cancéropôle Île-de-France

Zitieren

APA

Loverre, A., Jneid, B., Delisle, F., Genest, M., Alkhoury, C., Antoniadou, K., & Manel, N. (2026). A dendritic cell autophagy–neutrophil axis limits intratumoral STING immunotherapy. Science Immunology, 11(122). https://doi.org/10.1126/sciimmunol.adw6399

Vancouver

Loverre A, Jneid B, Delisle F, Genest M, Alkhoury C, Antoniadou K, et al. A dendritic cell autophagy–neutrophil axis limits intratumoral STING immunotherapy. Science Immunology. 2026;11(122). doi:10.1126/sciimmunol.adw6399

BibTeX
@article{Loverre2026,
  author = {Loverre, Adriana and Jneid, Bakhos and Delisle, Fabien and Genest, Magali and Alkhoury, Chantal and Antoniadou, Konstantina and Manel, Nicolas},
  title = {A dendritic cell autophagy–neutrophil axis limits intratumoral STING immunotherapy},
  journal = {Science Immunology},
  year = {2026},
  volume = {11},
  number = {122},
  doi = {10.1126/sciimmunol.adw6399}
}
Kostenlos starten →